Reuters logo
in 6 months
BRIEF-VenBio "intends to evaluate all of its legal options" on Immunomedics partnership deal
February 10, 2017 / 9:27 PM / in 6 months

BRIEF-VenBio "intends to evaluate all of its legal options" on Immunomedics partnership deal

1 Min Read

Feb 10 (Reuters) - venBio Select Advisor LLC:

* venBio Select Advisor LLC - beneficial owner of approximately 10.5 million shares, or 9.9 percent, of Immunomedics Inc

* venBio Select Advisor LLC - "intends to evaluate all of its legal options" Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below